The Food and Drug Administration issued a warning letter to Hims & Hers Health Inc. (NYSE: HIMS) on September 9 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE